HNO

, Volume 52, Issue 3, pp 208–218

HPV-assoziierte Tonsillenkarzinome

Ein Update
  • J. P. Klussmann
  • S. Dinh
  • O. Guntinas-Lichius
  • C. Wittekindt
  • S. Weißenborn
  • U. Wieland
  • H. P. Dienes
  • T. Hoffmann
  • E. Smith
  • L. Turek
  • E. J. M. Speel
  • H. J. Pfister
Leitthema

Zusammenfassung

Etablierte Risikofaktoren für die Entwicklung von Kopf-Hals-Karzinomen sind der chronische Nikotin- und Alkoholkonsum. Zwar wurde schon länger vermutet, dass humane Papillomviren (HPV) ebenfalls eine Rolle spielen könnten, aber erst kürzlich veröffentlichte Studien geben eine ausreichende Grundlage, dass die Infektion mit onkogenen [High-risk- (HR-)] HPV als Risikofaktor für die Entwicklung von Kopf-Hals-Karzinomen anzusehen ist. Mindestens die Hälfte aller Tonsillenkarzinome enthalten HR-HPV. Für das Zervixkarzinom wurde die HPV-induzierte Karzinogenese intensiv untersucht, und zunehmend können Parallelen für das Tonsillenkarzinom nachgewiesen werden. Die vorliegende Übersicht stellt hierzu den aktuellen Wissensstand dar und fasst die bisher bekannten molekularbiologischen Aspekte hierzu zusammen. Die Abgrenzung der HPV-positiven Kopf-Hals-Karzinome gewinnt zunehmend an klinischer Bedeutung, da der HPV-Status der Karzinome sowohl Auswirkungen auf Risikofaktoren als auch auf die Prognose hat.

Schlüsselwörter

Kopf-Hals-Karzinome Tonsillenkarzinom Oropharynxkarzinom Humane Papillomviren (HPV) Prognose 

Abstract

The major risk factors for head and neck squamous cell carcinomas (HNSCC) are considered to be tobacco and alcohol. A link between oncogenic types of the human papilloma virus (HPV) and the risk of HNSCC has been suggested in the literature. However, the causal link is now becoming more firmly established on the basis of recent analyses. About 20% of all HNSCC and more than 50% of tonsillar cancers contain HR-HPV. The causal role of HPV-infection in carcinogenesis and the molecular mechanisms involved could thus far be best elucidated in the case of cervical carcinomas. New insights and increasing evidence for the analogy of HPV-positive HNSCC with cervical cancer are discussed. The definition of HPV-positive HNSCC has become more important due to the implications for risk factors and prognosis.

Keywords

Head and neck squamous cell carcinomas (HNSCC) Tonsillar carcinoma Oropharyngeal carcinoma Human papilloma virus (HPV) Prognosis 

Literatur

  1. 1.
    Andl T, Kahn T, Pfuhl A et al. (1998) Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res 58: 5–13PubMedGoogle Scholar
  2. 2.
    Balz V, Scheckenbach K, Gotte K, Bockmuhl U, Petersen I, Bier H (2003) Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2–11 and human papillomavirus 16/18 e6 transcripts in 123 unselected tumor specimens. Cancer Res 63: 1188–1191PubMedGoogle Scholar
  3. 3.
    Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55: 244–265Google Scholar
  4. 4.
    Brandsma JL, Abramson AL (1989) Association of papillomavirus with cancers of the head and neck. Arch Otolaryngol Head Neck Surg 115: 621–625PubMedGoogle Scholar
  5. 5.
    Capone RB, Pai SI, Koch WM et al. (2000) Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma. Clin Cancer Res 6: 4171–4175PubMedGoogle Scholar
  6. 6.
    Cooper K, Herrington CS, Stickland JE, Evans MF, McGee JO (1991) Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridisation. J Clin Pathol 44: 990–996PubMedGoogle Scholar
  7. 7.
    Cruz IB, Snijders PJ, Steenbergen RD, Meijer CJ, Snow GB, Walboomers JM, van der Waal I (1996) Age-dependence of human papillomavirus DNA presence in oral squamous cell carcinomas. Eur J Cancer B Oral Oncol 32B: 55–62PubMedGoogle Scholar
  8. 8.
    Forastiere A, Koch W, Trotti A, Sidransky D (2001) Head and neck cancer. N Engl J Med 345: 1890–1900PubMedGoogle Scholar
  9. 9.
    Franceschi S, Munoz N, Bosch XF, Snijders PJ, Walboomers JM (1996) Human papillomavirus and cancers of the upper aerodigestive tract: a review of epidemiological and experimental evidence. Cancer Epidemiol Biomarkers Prev 5: 567–575PubMedGoogle Scholar
  10. 10.
    Franceschi S, Munoz N, Snijders PJ (2000) How strong and how wide is the link between HPV and oropharyngeal cancer? Lancet 356: 871–872CrossRefPubMedGoogle Scholar
  11. 11.
    Friesland S, Mellin H, Munck-Wikland E, Nilsson A, Lindholm J, Dalianis T, Lewensohn R (2001) Human papilloma virus (HPV) and p53 immunostaining in advanced tonsillar carcinoma--relation to radiotherapy response and survival. Anticancer Res 21: 529–534PubMedGoogle Scholar
  12. 12.
    Frisch M, Biggar RJ (1999) Aetiological parallel between tonsillar and anogenital squamous-cell carcinomas. Lancet 354: 1442–1443PubMedGoogle Scholar
  13. 13.
    Gillison ML, Koch WM, Capone RB et al. (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92: 709–720Google Scholar
  14. 14.
    Gillison ML, Koch WM, Shah KV (1999) Human papillomavirus in head and neck squamous cell carcinoma: are some head and neck cancers a sexually transmitted disease? Curr Opin Oncol 11: 191–199PubMedGoogle Scholar
  15. 15.
    Hafkamp HC, Speel EJ, Haesevoets A et al. (2003) A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and p53 overexpression in the absence of mutations in exon 5–8. Int J Cancer 107: 394–400CrossRefPubMedGoogle Scholar
  16. 16.
    Hauser U, Balz V, Carey TE, Grenman R, Van Lierop A, Scheckenbach K, Bier H (2002) Reliable detection of p53 aberrations in squamous cell carcinomas of the head and neck requires transcript analysis of the entire coding region. Head Neck 24: 868–873CrossRefPubMedGoogle Scholar
  17. 17.
    Hemminki K, Dong C, Frisch M (2000) Tonsillar and other upper aerodigestive tract cancers among cervical cancer patients and their husbands. Eur J Cancer Prev 9: 433–437PubMedGoogle Scholar
  18. 18.
    Herrero R, Castellsague X, Munoz N, Snijders PJ, Pawlita M, Viscidi R, Franceschi S (2002) Multicentric case-control study of HPV and oral cancers. 20th International Papillomavirus Conference, 4.–9. Oktober 2002, Paris, O 006 (Abstract)Google Scholar
  19. 19.
    Jeon S, Lambert PF (1995) Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci USA 92: 1654–1658PubMedGoogle Scholar
  20. 20.
    Kahn T, Turazza E, Ojeda R, Bercovich A, Stremlau A, Lichter P, Poustka A, Grinstein S, zur Hausen H (1994) Integration of human papillomavirus type 6a DNA in a tonsillar carcinoma: chromosomal localization and nucleotide sequence of the genomic target region. Cancer Res 54: 1305–1312PubMedGoogle Scholar
  21. 21.
    Klaes R, Friedrich T, Spitkovsky D et al. (2001) Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92: 276–284PubMedGoogle Scholar
  22. 22.
    Klaes R, Woerner SM, Ridder R et al. (1999) Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res 59: 6132–6136PubMedGoogle Scholar
  23. 23.
    Klussmann JP, Gultekin E, Weissenborn SJ et al. (2003) Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 162: 747–753PubMedGoogle Scholar
  24. 24.
    Klussmann JP, Weissenborn S, Wieland U et al. (2001) Prevalence, distribution and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 92: 2875–2884PubMedGoogle Scholar
  25. 25.
    Klussmann JP, Weissenborn S, Fuchs PG (2001) Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 345: 376Google Scholar
  26. 26.
    Klussmann JP, Weissenborn SJ, Wieland U, Dries V, Eckel HE, Pfister HJ, Fuchs PG (2003) Human papillomavirus-positive tonsillar carcinomas: a different tumor entity? Med Microbiol Immunol (Berl) 192: 129–132Google Scholar
  27. 27.
    Kobayashi Y, Yoshinouchi M, Tianqi G et al. (1998) Presence of human papilloma virus DNA in pelvic lymph nodes can predict unexpected recurrence of cervical cancer in patients with histologically negative lymph nodes. Clin Cancer Res 4: 979–983PubMedGoogle Scholar
  28. 28.
    Koutsky LA, Ault KA, Wheeler CM et al. (2002) A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 347: 1645–1651Google Scholar
  29. 29.
    Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM (2001) Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer 92: 805–813CrossRefPubMedGoogle Scholar
  30. 30.
    McKaig RG, Baric RS, Olshan AF (1998) Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head Neck 20: 250–265PubMedGoogle Scholar
  31. 31.
    Mellin H, Dahlgren L, Munck-Wikland E, Lindholm J, Rabbani H, Kalantari M, Dalianis T (2002) Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer 102: 152–158CrossRefPubMedGoogle Scholar
  32. 32.
    Mellin H, Friesland S, Lewensohn R, Dalianis T, Munck-Wikland E (2000) Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer 89: 300–304CrossRefPubMedGoogle Scholar
  33. 33.
    Miller CS, Johnstone BM (2001) Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982–1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91: 622–635Google Scholar
  34. 34.
    Mork J, Lie AK, Glattre E et al. (2001) Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 344: 1125–1131PubMedGoogle Scholar
  35. 35.
    Muderspach L, Wilczynski S, Roman L et al. (2000) A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive. Clin Cancer Res 6: 3406–3416PubMedGoogle Scholar
  36. 36.
    Niedobitek G, Pitteroff S, Herbst H, Shepherd P, Finn T, Anagnostopoulos I, Stein H (1990) Detection of human papillomavirus type 16 DNA in carcinomas of the palatine tonsil. J Clin Pathol 43: 918–921PubMedGoogle Scholar
  37. 37.
    Paz IB, Cook N, Odom-Maryon T, Xie Y, Wilczynski SP (1997) Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer’s tonsillar ring. Cancer 79: 595–604PubMedGoogle Scholar
  38. 38.
    Pintos J, Franco EL, Black MJ, Bergeron J, Arella M (1999) Human papillomavirus and prognoses of patients with cancers of the upper aerodigestive tract. Cancer 85: 1903–1909CrossRefPubMedGoogle Scholar
  39. 39.
    Rice PS, Mant C, Cason J, Bible JM, Muir P, Kell B, Best JM (2000) High prevalence of human papillomavirus type 16 infection among children. J Med Virol 61: 70–75CrossRefPubMedGoogle Scholar
  40. 40.
    Ritchie JM, Smith EM, Summersgill KF et al. (2003) Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 104: 336–344CrossRefPubMedGoogle Scholar
  41. 41.
    Rosl F, Lengert M, Albrecht J, Kleine K, Zawatzky R, Schraven B, zur Hausen H (1994) Differential regulation of the JE gene encoding the monocyte chemoattractant protein (MCP-1) in cervical carcinoma cells and derived hybrids. J Virol 68: 2142–2150PubMedGoogle Scholar
  42. 42.
    Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T (1998) Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 153: 1741–1748PubMedGoogle Scholar
  43. 43.
    Schwartz SM, Daling JR, Doody DR et al. (1998) Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 90: 1626–1636Google Scholar
  44. 44.
    Sisk EA, Bradford CR, Jacob A et al. (2000) Human papillomavirus infection in „young“ vs. „old“ patients with squamous cell carcinoma of the head and neck. Head Neck 22: 649–657PubMedGoogle Scholar
  45. 45.
    Smith EM, Hoffman HT, Summersgill KS, Kirchner HL, Turek LP, Haugen TH (1998) Human papillomavirus and risk of oral cancer. Laryngoscope 108: 1098–1103CrossRefPubMedGoogle Scholar
  46. 46.
    Smith EM, Ritchie JM, Summersgill KF et al. (2003) Risks associated with human papillomavirus infection in oral and oropharynx. Int J Cancer (in press)Google Scholar
  47. 47.
    Snijders PJ, Cromme FV, van den Brule AJ, Schrijnemakers HF, Snow GB, Meijer CJ, Walboomers JM (1992) Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology. Int J Cancer 51: 845–850PubMedGoogle Scholar
  48. 48.
    Snijders PJ, Scholes AG, Hart CA et al. (1996) Prevalence of mucosotropic human papillomaviruses in squamous-cell carcinoma of the head and neck. Int J Cancer 66: 464–469PubMedGoogle Scholar
  49. 49.
    Snijders PJ, van den Brule AJ, Schrijnemakers HF, Raaphorst PM, Meijer CJ, Walboomers JM (1992) Human papillomavirus type 33 in a tonsillar carcinoma generates its putative E7 mRNA via two E6* transcript species which are terminated at different early region poly(A) sites. J Virol 66: 3172–3178PubMedGoogle Scholar
  50. 50.
    Steinberg BM, Di Lorenzo TP (1996) A possible role for human papillomaviruses in head and neck cancer. Cancer Metastasis Rev 15: 91–112PubMedGoogle Scholar
  51. 51.
    Strome SE, Savva A, Brissett AE et al. (2002) Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations. Clin Cancer Res 8: 1093–1100PubMedGoogle Scholar
  52. 52.
    Summersgill KF, Smith EM, Levy BT, Allen JM, Haugen TH, Turek LP (2001) Human papillomavirus in the oral cavities of children and adolescents. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91: 62–69CrossRefPubMedGoogle Scholar
  53. 53.
    Summersgill KF, Smith EM, Ritchie JM, Hoffman HT, Klussmann JP, Dienes HP, Haugen TH (2004) Human papillomavirus in malignant tumors of the head and neck (Manuskript in Vorbereitung)Google Scholar
  54. 54.
    Tominaga S, Fukushima K, Nishizaki K, Watanabe S, Masuda Y, Ogura H (1996) Presence of human papillomavirus type 6f in tonsillar condyloma acuminatum and clinically normal tonsillar mucosa. Jpn J Clin Oncol 26: 393–397PubMedGoogle Scholar
  55. 55.
    Tsuchiya H, Tomita Y, Shirasawa H, Tanzawa H, Sato K, Simizu B (1991) Detection of human papillomavirus in head and neck tumors with DNA hybridization and immunohistochemical analysis. Oral Surg Oral Med Oral Pathol 71: 721–725PubMedGoogle Scholar
  56. 56.
    van Houten VM, Snijders PJ, van den Brekel MW et al. (2001) Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer 93: 232–235CrossRefPubMedGoogle Scholar
  57. 57.
    Vokes EE, Weichselbaum RR, Lippman SM, Hong WK (1993) Head and neck cancer. N Engl J Med 328: 184–194PubMedGoogle Scholar
  58. 58.
    Wagner M, Klussmann JP, Fangmann R et al. (2001) Cyclin-dependent kinase-inhibitor 1 (CDKN1A) in the squamous epithelium of the oropharynx: possible implications of molecular biology and compartmentation. Anticancer Res 21: 333–345PubMedGoogle Scholar
  59. 59.
    Wentzensen N, Ridder R, Klaes R, Vinokurova S, Schaefer U, Doeberitz MK (2002) Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions. Oncogene 21: 419–426CrossRefPubMedGoogle Scholar
  60. 60.
    Wiest T, Schwarz E, Enders C, Flechtenmacher C, Bosch FX (2002) Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 21: 1510–1517CrossRefPubMedGoogle Scholar
  61. 61.
    Wilczynski SP, Lin BT, Xie Y, Paz IB (1998) Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma. Am J Pathol 152: 145–156PubMedGoogle Scholar
  62. 62.
    Wollenberg B, Ollesch A, Maag K, Funke I, Wilmes E (1994) Micrometastases in bone marrow of patients with cancers in the head and neck area. Laryngorhinootologie 73: 88–93PubMedGoogle Scholar
  63. 63.
    Zumbach K, Hoffmann M, Kahn T et al. (2000) Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in patients with head-and-neck squamous-cell carcinoma. Int J Cancer 85: 815–818CrossRefPubMedGoogle Scholar
  64. 64.
    zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342–350CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • J. P. Klussmann
    • 1
    • 8
  • S. Dinh
    • 1
  • O. Guntinas-Lichius
    • 1
  • C. Wittekindt
    • 1
  • S. Weißenborn
    • 2
  • U. Wieland
    • 2
  • H. P. Dienes
    • 3
  • T. Hoffmann
    • 4
  • E. Smith
    • 5
  • L. Turek
    • 6
  • E. J. M. Speel
    • 7
  • H. J. Pfister
    • 2
  1. 1.Klinik und Poliklinik für Hals-Nasen-Ohren-Heilkunde des Klinikum der Universität zu Köln
  2. 2.Institut für Virologie der Universität zu Köln
  3. 3.Institut für Pathologie der Universität zu Köln
  4. 4.Klinik und Poliklinik für Hals-Nasen-Ohren-Heilkunde der Universität Düsseldorf
  5. 5.Department of EpidemiologyUniversity of IowaIowa CityUSA
  6. 6.Department of PathologyUniversity of IowaIowa CityUSA
  7. 7.Department of Molecular Cell BiologyResearch Institute Growth and Development, University of MaastrichtNiederlande
  8. 8.HNO-Klinik der Universität zu KölnKöln

Personalised recommendations